A recent retrospective study by researchers using data from the SHaRe Registry found that women with hypertrophic cardiomyopathy have an increased risk of death and/or severe heart failure symptoms when compared to their male counterparts. This study also found that women tended to be older when diagnosed with HCM than men.
This study echoes a 2017 study from Mayo Clinic with similar findings.
Editor’s Note: It is clear that serious research into gender differences in HCM is needed. And, it is vitally important that women with HCM be persistent and diligent in obtaining expert care for their HCM. Their lives depend on it!